- Home
- JYD vs PMN Comparison
JYD vs PMN Comparison
Compare JYD & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYD
- PMN
- Stock Information
- Founded
- JYD 2001
- PMN 2004
- Country
- JYD China
- PMN Canada
- Employees
- JYD N/A
- PMN N/A
- Industry
- JYD Oil Refining/Marketing
- PMN Pharmaceuticals and Biotechnology
- Sector
- JYD Consumer Discretionary
- PMN Health Care
- Exchange
- JYD Nasdaq
- PMN Nasdaq
- Market Cap
- JYD 18.9M
- PMN 22.3M
- IPO Year
- JYD 2023
- PMN N/A
- Fundamental
- Price
- JYD $0.14
- PMN $0.46
- Analyst Decision
- JYD
- PMN Strong Buy
- Analyst Count
- JYD 0
- PMN 3
- Target Price
- JYD N/A
- PMN $4.33
- AVG Volume (30 Days)
- JYD 940.9K
- PMN 3.1M
- Earning Date
- JYD 10-24-2025
- PMN 11-13-2025
- Dividend Yield
- JYD N/A
- PMN N/A
- EPS Growth
- JYD N/A
- PMN N/A
- EPS
- JYD N/A
- PMN N/A
- Revenue
- JYD $77,444,271.00
- PMN N/A
- Revenue This Year
- JYD N/A
- PMN N/A
- Revenue Next Year
- JYD N/A
- PMN N/A
- P/E Ratio
- JYD N/A
- PMN N/A
- Revenue Growth
- JYD 13.54
- PMN N/A
- 52 Week Low
- JYD $0.09
- PMN $0.38
- 52 Week High
- JYD $8.00
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- JYD 36.82
- PMN 43.27
- Support Level
- JYD $0.13
- PMN $0.39
- Resistance Level
- JYD $0.16
- PMN $0.45
- Average True Range (ATR)
- JYD 0.01
- PMN 0.04
- MACD
- JYD -0.00
- PMN 0.00
- Stochastic Oscillator
- JYD 34.21
- PMN 38.24
About JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, supply chain management, and other value-added services.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.